Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials
Schadendorf, Dirk, Wolchok, Jedd D, Hodi, F Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C Lance, Lao, Christopher D, Chesney, Jason, Robert, Caroline, Grossmann, Kenneth, McDermott, David, Walker, Dana, Bhore, Rafia, Larkin, James, Postow, Michael A
Published in Journal of clinical oncology (01.12.2017)
Published in Journal of clinical oncology (01.12.2017)
Get full text
Journal Article
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Larkin, James, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Lao, Christopher D, Cowey, C. Lance, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferrucci, Pier F, Smylie, Michael, Hogg, David, Hill, Andrew, Márquez-Rodas, Ivan, Haanen, John, Guidoboni, Massimo, Maio, Michele, Schöffski, Patrick, Carlino, Matteo S, Lebbé, Céleste, McArthur, Grant, Ascierto, Paolo A, Daniels, Gregory A, Long, Georgina V, Bastholt, Lars, Rizzo, Jasmine I, Balogh, Agnes, Moshyk, Andriy, Hodi, F. Stephen, Wolchok, Jedd D
Published in The New England journal of medicine (17.10.2019)
Published in The New England journal of medicine (17.10.2019)
Get full text
Journal Article
Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA
Cowey, C Lance, Mahnke, Lisa, Espirito, Janet, Helwig, Christoph, Oksen, Dina, Bharmal, Murtuza
Published in Future oncology (London, England) (01.08.2017)
Published in Future oncology (London, England) (01.08.2017)
Get full text
Journal Article
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Wolchok, Jedd D, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C. Lance, Lao, Christopher D, Wagstaff, John, Schadendorf, Dirk, Ferrucci, Pier F, Smylie, Michael, Dummer, Reinhard, Hill, Andrew, Hogg, David, Haanen, John, Carlino, Matteo S, Bechter, Oliver, Maio, Michele, Marquez-Rodas, Ivan, Guidoboni, Massimo, McArthur, Grant, Lebbé, Celeste, Ascierto, Paolo A, Long, Georgina V, Cebon, Jonathan, Sosman, Jeffrey, Postow, Michael A, Callahan, Margaret K, Walker, Dana, Rollin, Linda, Bhore, Rafia, Hodi, F. Stephen, Larkin, James
Published in The New England journal of medicine (05.10.2017)
Published in The New England journal of medicine (05.10.2017)
Get full text
Journal Article
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Weber, Jeffrey, Mandala, Mario, Del Vecchio, Michele, Gogas, Helen J, Arance, Ana M, Cowey, C. Lance, Dalle, Stéphane, Schenker, Michael, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Grob, Jean-Jacques, Butler, Marcus O, Middleton, Mark R, Maio, Michele, Atkinson, Victoria, Queirolo, Paola, Gonzalez, Rene, Kudchadkar, Ragini R, Smylie, Michael, Meyer, Nicolas, Mortier, Laurent, Atkins, Michael B, Long, Georgina V, Bhatia, Shailender, Lebbé, Celeste, Rutkowski, Piotr, Yokota, Kenji, Yamazaki, Naoya, Kim, Tae M, de Pril, Veerle, Sabater, Javier, Qureshi, Anila, Larkin, James, Ascierto, Paolo A
Published in The New England journal of medicine (09.11.2017)
Published in The New England journal of medicine (09.11.2017)
Get full text
Journal Article
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, James, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean Jacques, Cowey, C. Lance, Lao, Christopher D, Schadendorf, Dirk, Dummer, Reinhard, Smylie, Michael, Rutkowski, Piotr, Ferrucci, Pier F, Hill, Andrew, Wagstaff, John, Carlino, Matteo S, Haanen, John B, Maio, Michele, Marquez-Rodas, Ivan, McArthur, Grant A, Ascierto, Paolo A, Long, Georgina V, Callahan, Margaret K, Postow, Michael A, Grossmann, Kenneth, Sznol, Mario, Dreno, Brigitte, Bastholt, Lars, Yang, Arvin, Rollin, Linda M, Horak, Christine, Hodi, F. Stephen, Wolchok, Jedd D
Published in The New England journal of medicine (02.07.2015)
Published in The New England journal of medicine (02.07.2015)
Get full text
Journal Article
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF -Mutant Melanoma
Hamid, Omid, Cowey, C Lance, Offner, Michelle, Faries, Mark, Carvajal, Richard D
Published in Cancers (24.10.2019)
Published in Cancers (24.10.2019)
Get full text
Journal Article
Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma
LANCE COWEY, C, AMIN, Chirag, MOORE, Dominic T, KIM, William Y, GODLEY, Paul A, WHANG, Young E, FIELDING, Julia R, KIMRYN RATHMELL, W, PRUTHI, Raj S, WALLEN, Eric M, NIELSEN, Matthew E, GRIGSON, Gayle, WATKINS, Cathy, NANCE, Keith V, CRANE, Jeffrey, JALKUT, Mark
Published in Journal of clinical oncology (20.03.2010)
Published in Journal of clinical oncology (20.03.2010)
Get full text
Journal Article
Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy
Cowey, C. Lance, Robert, Nicholas J., Espirito, Janet L., Davies, Kalatu, Frytak, Jennifer, Lowy, Israel, Fury, Matthew G.
Published in Cancer medicine (Malden, MA) (01.10.2020)
Published in Cancer medicine (Malden, MA) (01.10.2020)
Get full text
Journal Article
The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics
Ribas, Antoni, Zhang, Weijiang, Chang, Ilsung, Shirai, Keisuke, Ernstoff, Marc S, Daud, Adil, Cowey, C Lance, Daniels, Gregory, Seja, Elizabeth, O'Laco, Elizabeth, Glaspy, John A, Chmielowski, Bartosz, Hill, Todd, Joe, Andrew K, Grippo, Joseph F
Published in Journal of clinical pharmacology (01.04.2014)
Published in Journal of clinical pharmacology (01.04.2014)
Get more information
Journal Article
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
Mandalá, Mario, Larkin, James, Ascierto, Paolo A, Del Vecchio, Michele, Gogas, Helen, Cowey, C Lance, Arance, Ana, Dalle, Stéphane, Schenker, Michael, Grob, Jean-Jacques, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Butler, Marcus O, Di Giacomo, Anna Maria, Lutzky, Jose, De La Cruz-Merino, Luis, Atkinson, Victoria, Arenberger, Petr, Hill, Andrew, Fecher, Leslie, Millward, Michael, Khushalani, Nikhil I, de Pril, Veerle, Lobo, Maurice, Weber, Jeffrey
Published in Journal for immunotherapy of cancer (01.08.2021)
Published in Journal for immunotherapy of cancer (01.08.2021)
Get full text
Journal Article
HIF1α and HIF2α exert distinct nutrient preferences in renal cells
Arreola, Alexandra, Cowey, C Lance, Coloff, Jonathan L, Rathmell, Jeffrey C, Rathmell, W Kimryn
Published in PloS one (30.05.2014)
Published in PloS one (30.05.2014)
Get full text
Journal Article
Administration of Cisplatin-Based Chemotherapy for Advanced Urothelial Carcinoma in the Community
Sonpavde, Guru, Watson, Deidre, Tourtellott, Marcia, Cowey, C. Lance, Hellerstedt, Beth, Hutson, Thomas E, Zhan, Feng, Vogelzang, Nicholas J
Published in Clinical genitourinary cancer (01.03.2012)
Published in Clinical genitourinary cancer (01.03.2012)
Get full text
Journal Article
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
Wolchok, Jedd D, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Lao, Christopher D, Cowey, C Lance, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferrucci, Pier Francesco, Smylie, Michael, Butler, Marcus O, Hill, Andrew, Márquez-Rodas, Ivan, Haanen, John B A G, Guidoboni, Massimo, Maio, Michele, Schöffski, Patrick, Carlino, Matteo S, Lebbé, Céleste, McArthur, Grant, Ascierto, Paolo A, Daniels, Gregory A, Long, Georgina V, Bas, Tuba, Ritchings, Corey, Larkin, James, Hodi, F Stephen
Published in Journal of clinical oncology (10.01.2022)
Published in Journal of clinical oncology (10.01.2022)
Get full text
Journal Article
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Ascierto, Paolo A, Del Vecchio, Michele, Mandalá, Mario, Gogas, Helen, Arance, Ana M, Dalle, Stephane, Cowey, C Lance, Schenker, Michael, Grob, Jean-Jacques, Chiarion-Sileni, Vanna, Márquez-Rodas, Iván, Butler, Marcus O, Maio, Michele, Middleton, Mark R, de la Cruz-Merino, Luis, Arenberger, Petr, Atkinson, Victoria, Hill, Andrew, Fecher, Leslie A, Millward, Michael, Khushalani, Nikhil I, Queirolo, Paola, Lobo, Maurice, de Pril, Veerle, Loffredo, John, Larkin, James, Weber, Jeffrey
Published in The lancet oncology (01.11.2020)
Published in The lancet oncology (01.11.2020)
Get full text
Journal Article
The Loss of Radiographic Enhancement in Primary Renal Cell Carcinoma Tumors Following Multitargeted Receptor Tyrosine Kinase Therapy is an Additional Indicator of Response
Cowey, C. Lance, Fielding, Julia R, Kimryn Rathmell, W
Published in Urology (Ridgewood, N.J.) (01.05.2010)
Published in Urology (Ridgewood, N.J.) (01.05.2010)
Get full text
Journal Article
Real-world treatment patterns and clinical outcomes among patients with advanced melanoma: A retrospective, community oncology-based cohort study (A STROBE-compliant article)
Cowey, C Lance, Liu, Frank Xiaoqing, Boyd, Marley, Aguilar, Kathleen M, Krepler, Clemens
Published in Medicine (Baltimore) (01.07.2019)
Published in Medicine (Baltimore) (01.07.2019)
Get full text
Journal Article